key: cord-0708995-k9nnignb
authors: El-Raheem, Ghada Omer Hamad Abd; Mohamed, Doaa Salih Ibrahim; Yousif, Maysoun Ahmed Awad; Elamin, Hind Eltayeb Salih
title: Characteristics and Severity of COVID-19 among Sudanese patients during the waves of the pandemic
date: 2021-10-28
journal: Sci Afr
DOI: 10.1016/j.sciaf.2021.e01033
sha: 4a15476615d9d1a252ff3347bd4b8fed5c548b3a
doc_id: 708995
cord_uid: k9nnignb

COVID-19 is associated with marked morbidity and mortality. COVID-19 symptoms ranged from mild symptoms to severe pneumonia requiring admission to intensive care unit. Imperial College reported that, this second wave in Khartoum is expected to be similar to the first wave. The aim of our study was to study the characteristics and severity of COVID-19 among Sudanese patients during the waves of the pandemic. A hospital-based analytical Cross-Sectional study assessed the characteristics of COVID-19 patients who attended Imperial Hospital since November 2020, Khartoum, Sudan. Data were collected, retrospectively, from the medical records of COVID-19 patients. The characteristics of the patients were recorded. The statistical package for social sciences (SPSS-23) was used to describe and analyse the data. Descriptive statistics and chi-square test were used; tests were considered statistically significant when p < 0.05. Of the 138 participants, 75.4% were aged above 60 years. Males were 61.6%. Severe cases were 37.7%, with higher rate in the third wave (p=0.000). Duration of hospitalization was ≤ 5 days in 60.9% of the cases, majority were from the 2nd wave (p=0.001). Comorbidities of COVID-19 patients were more among non-severe cases (p=0.001). COVID-19 symptoms were more prevalent in non-severe cases. Complications were more in severe cases (p=0.000). Odds ratio of having ischemic stroke was 6.833 [95%CI: 2.092-22.321] based on COVID-19 severity. The elderly population were the majority. More males were getting admitted. Atypical symptoms were reported besides the common symptoms. Wider multi-centre studies are recommended in order to complete the big picture of COVID-19 in Sudan.

Corona viruses are RNA viruses, enclosed in a spiked envelope giving them an appearance similar to crowns. In the year of 2019, a new coronavirus has appeared. This new virus can cause "Severe Acute Respiratory Syndrome" thus referred to as (SARS-CoV-2). Chinese Scientists and the world health organization (WHO) called it COVID-19 [1, 2] The WHO has declared this outbreak as a pandemic in March 2020 [3] . COVID-19 was originated in bats [2, 4] then transferred to humans with the first spread from Wuhan, China [4] . The symptoms of COVID-19 range from mild symptoms resulting in fever, cough, shortness of breath and fatigue to severe pneumonia requiring admission to intensive care unit (ICU) and mechanical ventilation [5] . Gastro intestinal (GI) symptoms were also reported [6] . All community members are susceptible to COVID-19 infection, but the vulnerable populations are children, old aged people and pregnant women [7] . As well as, people with comorbidities especially diabetes, which was associated with COVID-19 severity [8] . COVID-19 is associated with marked morbidity and mortality related mostly to respiratory conditions [9] . Since the start of COVID-19 infected cases in December 2019, the disease had spread worldwide causing increasing fatalities daily [10] . Imperial College at the United Kingdom, reported that, this second wave in Khartoum is expected to be of the same size as the first wave [11] . In Sudan, the federal ministry of health had reported COVID-19 cases on daily bases (http://sho.gov.sd/corona/ ). In this study, severity of infection was defined based on the cases admission; general ward cases were the non-severe cases and ICU cases were the severe cases. The aim of our study was to describe and compare the characteristics and severity of infection among patients at different waves of the pandemic. We focused on infection severity because of its economic impact on healthcare system and on the families of the patients, besides the risk of mortality.

A hospital-based analytical Cross-Sectional study was implemented to compare the characteristics of the patients and the disease at the second wave and the third wave of the pandemic. The study assessed the characteristics of COVID-19 patients who attended Imperial Hospital, as well as, the infection severity and complications. Based on the reports of the Federal Ministry of Health in Sudan (http://sho.gov.sd/corona/ ), infection rate had increased in November and December 2020 indicating the second wave of the pandemic. Then another peak occurred in April till May, 2021indicar the third peak in Khartoum, Sudan. Imperial Hospital is a 60 bed hospital containing three isolation wards, two of them are general isolation wards and one is an isolation intensive care unit (ICU), each of the general wards had 10 beds capacity, while the ICU had 8 beds capacity. Data were collected retrospectively, through an anonymous data collection sheet. Data were extracted from the medical records of COVID-19 patients hospitalized at the time of the data collection. Out of total COVID-19 admitted cases which were 179 cases, a sample of 138 files of adult COVID-19 patients was collected through stratified random sampling technique from the hospital registry. Files were divided into two strata based on the date of admission; second wave and third wave. The equation of sample size estimation used for each stratum was n=N/1+Nd 2 , where n is the estimated sample size, N, the total number of patients records, d the degree of accuracy set at 0.05. The total number of patients admitted during the second wave (from November to December, 2020) were 143 patients; out of which, 105 patients were randomly selected. The total number of patients admitted during the third wave (between April and May, 2021) were 36 patients; out of which, 33 patients were randomly selected. Characteristics of patients as age, gender, associated comorbidities were recorded. The statistical package for social sciences (SPSS version 23) was used to describe and analyse the data. Chi-square test was done to assess the differences between variables, it was considered statistically significant when p ≤ 0.05. Confidentiality of participants was assured through the use of an anonymous research tool. Informed consents from the patients/ surrogate decision makers were obtained, voluntary, by contacting them through their registered phone numbers. The collected data were used strictly for the purpose of the study objectives.

138 patients were involved in this study. 24.6% of the patients were aged 60 years or below, while 75.4% were aged more than 60 years. No statistically significant difference was found in the age between the patients admitted in the second wave and the patients admitted in the third wave (p= 0.687). Regarding gender, 61.6% of the patients were males and 38.4% were females with no statistically significant difference(p=0.586) between second and third waves of the pandemic. Patients who had comorbid conditions were 65.9%. Of those, 85.7% were admitted during the second wave, while, 14.3% were admitted in the third wave (p=0.000). Admission of patients was classified into two based on the infection severity; general isolation ward for non-severe cases and intensive care unit (ICU) for severe cases. 98.8% of the patients admitted to the general isolation ward were from the second wave of the pandemic, while, only 1.2% were from the third wave.

In the other hand, 38.55 of the severe cases were from the second wave and 61.5% were from the third wave (p=0.000). Complications of COVID-19 were reported; patients who suffered from COVID-19 complications were 20.3%. Of those patients, 32.1% were from the second wave and 67.95 from the third wave (p=0.000). Duration of hospital stay was recorded in days, patients who had hospital stay of 5 days or less were 60.9% of all the patients and patients who had > 5 days of hospital stay were 39.1%. Of the 105 patients of the 2 nd wave, 33 patients had > 5 days duration of hospital stay. In the other hand, of the 33 patients admitted in the 3 rd wave, 21 patients had >5 days of hospital stay (p=0.001). Table 1 below shows the details. 

The most prevalent comorbidities were diabetes (DM) and hypertension (HTN) comprising 43% and 42% of participants respectively. Of the diabetic patients, 82% were from the 2 nd wave and 18% were from the 3 rd wave (Chi 2 =1.816, p=0.178). While, among hypertensive patients, 84% were from the 2 nd wave and 16% from the 3rd wave (Chi 2 =3.876, p=0.049). Patients who had both DM and hypertension were 26% and of those, 81% were from the 2 nd wave and 19% from the 2nd wave (Chi 2 =0.535, p=0.465).

Only 4% of the patients had ischemic heart disease (IHD), 80% of them from the 2 nd wave, while 20% were from the 3 rd wave (Chi 2 =0.044, p=0.834), figure 1.

Only 20.3% of the COVID-19 patients developed complications. 12% of all the study participants had developed ischemic stroke, 71% of them were from the 3 rd wave, while, only 29% were from the second wave (chi 2 = 23.215, p=0.000). Acute kidney injury (AKI) was reported in 5% of all the patients, 57% from the second wave and 43% of the third wave (chi 2 = 1.454, p=0.228). In the other hand, sepsis was reported in 3% of the patients and all were from the third wave (Chi 2 =13,107, p=0.000). 

Severity of the patient status was assessed based on the admission, general ward admission was for the non-severe cases, while, severe cases were admitted to the ICU.COVID-19 symptoms and complications were assessed with regards to severity. As well as characteristics of patients were assessed based on severity status.

Fever was the most prevalent symptom (77%); especially among the non-severe cases (88%) of the patients in the general ward (Chi2= 10.323, p=0.001). Cough was the second frequently reported symptom (70%). Although, it was mostly prevalent in nonsevere cases, no statistically significant difference was found between severe and nonsevere cases (Chi2= 0.356, p=0.551). The third prevalent symptom reported was shortness of breath (69%), followed by fatigue (31%), gastro-intestinal (GI) symptoms (14%), headache (7%) and loss of consciousness (4%). All of these symptoms had no statistically significant difference between severe and non-severe cases (p> 0.05), figure   3 .

Characteristics of patients were assessed with regards to severity of COVID-19 infection.

Both age and gender had no statistically significant difference between severe and non-severe cases (p>0.05). Interestingly, comorbidities were more prevalent in the non-severe cases (74.7%,65/87) than the severe cases (p=0.001). in the other hand, COVID-19 complications were more prevalent ibn the severe cases (71.4%, 20/28) than the nonsevere cases (p=0.000). With regards to the duration of hospital stay, most of the cases (72.6%,61/84) with short duration of stay (≤ 5 days) were non-severe cases. In the other hand, 53.7 (29/54) of the cases with longer duration of stay (> 5 days) were severe cases (p=0.002). 

On detailing the comorbidities and complications in relation to infection severity, DM had an odds ratio of 0.486 being more prevalent in non-severe cases (p=0.047). As well as, HTN (p=0.037) with odds ratio of 0.466, other comorbidities had no statistically significant difference between severe and non-severe cases (p>0.05), table 3, figure 4 . On assessing complications related to COVID-19 infection, ischemic stroke had odds ratio= 6.833 being more prevalent in severe cases (p=0.000). Sepsis was reported for severe cases only (p=0.009). Table 3 and figure 4 below show the details. 

The emergence of COVID-19 pandemic has represented a major crisis for populations around the world. Unfortunately, there is no enough published reports from Sudan and details about disease characteristics, severity, mortality and associated comorbidities remain unclear. Therefore, our study has examined the characteristic of COVID-19

disease during the waves of pandemic in Sudan. In this study, we found the majority of COVID-19 cases were males (61.6%), which could be attributed to the higher proportion of males during the second surge (77.6%), this was consistent with Fang X et al.

systematic review reporting increased percentages as high as 83% [12] . With regard to the third wave, there were no sex differences found in the number of cases and males comprised (57.6%, 19/33), giving almost equal percentages of males and females.

Another meta-analysis study reported that males comprised 60% of COVID-19 patients [13] . Remarkably, 75.4% of our patients were elderly, aged more than 60 years that was in line with Fang X et al. [12] . Compared with previous studies, a higher percentage of our hospitalized patients required ICU admission. 37.7 % required ICU care compared with proportions of 5% up to 31.7% of patients mentioned in previous reports [14, 15] .

When assessing severity based on COVID-19 waves, the third wave had a very high percentage of ICU admission (61.5%) compared to the second wave (38.5%), p=0.000.

Both males and females in this study required ICU care with higher percentage among females (43.4%) more than males (34.1%), contradictory to a previous study [16] , Gulati et al. reported that more males required ICU care. According to our data, the prevalence of COVID-19 infection was linked to underlying comorbidities, the most common of which was DM (43%) followed by HTN (42%). The majority of patients admitted to Imperial Hospital (65.9%) had co-morbidities and this percentage was notably higher than the percentage reported by Thai et al. where comorbidities were found to be 11.3% of their patients [15] . As in previous studies, 26% of all patients had both diabetes and Hypertension [12, 17] . On the other hand, around 40% of our study participants had either DM or HTN, and this percentage was higher than the findings reported in previously published study [14] . The most frequently reported COVID-19 symptoms were fever (77%), which agrees with the findings published in previous studies [1, 13, [18] [19] [20] [18] . Furthermore, Shortness of breath was one of the most frequent clinical symptoms in our study (69%), this was higher than what previously published with percentages ranging from 18.6% to 55% [14] . Approximately 31.4% of our patients complained of fatigue in contrast to the published data. describing fatigue as one of the most frequent symptoms (38.1% to 69.6%). The incidence of atypical GI symptoms such as vomiting, diarrhoea and loss of appetite, was calculated as 14% in our study patients, consistent with previous studies [21, 22] , contrary to other studies indicated that GI symptoms were not as common [1, 13, 23] . All symptoms had no statistically significant difference in prevalence among severe and non-severe cases (p>0.05), except for fever; it was more prevalent in non-severe cases with a statistically significant difference (p=0.001). On assessing the complications associated with COVID-19 infection, acute kidney injury and ischemic stroke were reported among the two waves, as in many studies [22, [24] [25] [26] [27] . 12% of our patients had developed ischemic stroke and this incidence was higher than ranges reported (0.9% -2.7%, 8%) [28, 29] .

Interestingly, prevalence of ischemic stroke differed drastically between the second and third waves (29% and 71%) respectively (p= 0.000). As well as, sepsis had prevailed in patients of the third wave only (p=0.000). In our study, 5% of patients had developed AKI, this was much lower than the incidence reported in study [25] , in which, 46% of patients had developed AKI. As for the duration of hospital stay among our patients, 60.9% had duration of 5 days or less, this was much lower than the documented median duration of hospitalization (21 days) in a published study [15] . The novelty in this paper is that it studied a population that is unknown for the international scientific field. 

Overall .In order to aid the national authorities towards control of the pandemic in Sudan and to prevent the emergence of future outbreaks, consistent and regulated surveillance of COVID-19 infection is essential to obtain the necessary data.

Approval was firstly obtained from the Medical administration of Imperial Hospital.

The study proposal was then submitted to the Administration of Innovation and Scientific Research at the State Ministry of Health (MOH), Khartoum. Expedited review was conducted by the IRB of the MOH and approval was granted. Another copy of the proposal was submitted to the Administration of Private Medical

Facilities. Regarding participants, the data were collected retrospectively from the medical records. Confidentiality of participants was assured through the use of an anonymous research tool. Informed consents from the patients / surrogate decision makers were obtained, voluntary, by contacting them through their registered phone numbers. The collected data were used strictly for the purpose of the study objectives.

All authors have read the final manuscript and gave their consent for the article to be 

All supporting data are available.

A comprehensive review of COVID-19 characteristics

SARS-CoV-2 and COVID-19: Th e most important research questions

Brief Review on COVID-19: The 2020 Pandemic Caused by SARS -CoV-2. Cureus

A Review of Coronavirus Disease-2019 (COVID-19)

Early epidemiological indicators, outcomes, and intervention s of COVID-19 pandemic: A systematic review

The COVID-19 epidemic

Current epidemiological and clinical feature s of COVID-19; a global perspective from

Srivas tava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

Respiratory conditions in coronavirus disease 2019 (COVI D-19): Important considerations regarding novel treatment strategies to reduce mo rtality. Med Hypotheses

Review of B urden, Clinical Definitions, and Management of COVID-19 Cases

Characterising COVID-19 epidemic dynamics and mortality underascertainment in Khartoum

Epidemiological, comorbidity factors with severity and prognosis of COVID-1 9: a systematic review and meta-analysis. Aging (Albany NY)

COVID-19 patients' clinical characteristics, discharge rate, and fatality r ate of meta-analysis

The hallmarks of COVID-19 disease

Factors associated with the durati on of hospitalisation among COVID-19 patients in Vietnam: A survival analysis

A Comprehensive Review of Manifestations of Novel Coro naviruses in the Context of Deadly COVID-19 Global Pandemic

Understanding of COVID-19 based on current evidence

Coronavirus disease 2019 (COVID-19): A literature rev iew

What we know so far: COVID-19 current clinical knowledge and resea rch

Characteristics of COVID-19 infection in Beijing

Remdesivir for the Treatment of COVID-19: A Syst ematic Review of the Literature

Extra-respiratory manifestations of COVID-19

Gastrointestinal Pres entation in COVID-19 in Indonesia: A Case Report

COVID-19-Related Stroke

AK I in Hospitalized Patients with COVID-19

COVID-19 presenting as stroke

COVID-19 and stroke: A review. Brain Hemorrhages

COVID-19 and ischemic stroke: a systematic re view and meta-summary of the literature

COVID-19 and the nervous system

The authors are grateful to Shurouq O. H. Abdelraheem, Faculty of Engineering, University of Khartoum for her assistance in the data entry process. The authors also acknowledge the cooperation of the departments of Imperial Hospital during the data collection.

The authors bore all the costs related to the study.

All authors have read the final manuscript and gave their approval for publication.GOHA: Got the ethical approval, wrote the manuscript, conducted the analysis and assisted in the data collection.DSIM: Facilitated the administrative arrangements at Imperial Hospital, assisted in the data collection and read the final manuscript prior to submission.

Collected the data, assisted in getting the ethical approval, read the first draft of the manuscript and proof read the final manuscript prior to submission.

Reviewed the drafted manuscript to check for plagiarism and English quality and proof read the final manuscript prior to submission.

The authors declared no competing interest.